Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Gut OncoMicrobiome Signatures (GOMS) as next-generation biomarkers for cancer immunotherapy
Andrew Maltez Thomas, Marine Fidelle, Bertrand Routy, et al.
Nature Reviews Clinical Oncology (2023) Vol. 20, Iss. 9, pp. 583-603
Closed Access | Times Cited: 61

Showing 1-25 of 61 citing articles:

Precision treatment in advanced hepatocellular carcinoma
Xupeng Yang, Chen Yang, Shu Zhang, et al.
Cancer Cell (2024) Vol. 42, Iss. 2, pp. 180-197
Open Access | Times Cited: 80
Longitudinal gut microbiome changes in immune checkpoint blockade-treated advanced melanoma
Johannes R. Björk, Laura A. Bolte, Andrew Maltez Thomas, et al.
Nature Medicine (2024) Vol. 30, Iss. 3, pp. 785-796
Open Access | Times Cited: 36
Aging and cancer
Léa Montégut, Carlos López-Otı́n, Guido Kroemer
Molecular Cancer (2024) Vol. 23, Iss. 1
Open Access | Times Cited: 27
Custom scoring based on ecological topology of gut microbiota associated with cancer immunotherapy outcome
Lisa Derosa, Valerio Iebba, Carolina Alves Costa Silva, et al.
Cell (2024) Vol. 187, Iss. 13, pp. 3373-3389.e16
Open Access | Times Cited: 27
A gut microbial signature for combination immune checkpoint blockade across cancer types
Ashray Gunjur, Yan Shao, Timothy Rozday, et al.
Nature Medicine (2024) Vol. 30, Iss. 3, pp. 797-809
Open Access | Times Cited: 21
Role of the microbiota in response to and recovery from cancer therapy
Stephen J. Blake, Yochai Wolf, Ben Boursi, et al.
Nature reviews. Immunology (2023) Vol. 24, Iss. 5, pp. 308-325
Closed Access | Times Cited: 35
Melanoma and microbiota: Current understanding and future directions
Bertrand Routy, Tanisha Jackson, Laura Mählmann, et al.
Cancer Cell (2023) Vol. 42, Iss. 1, pp. 16-34
Open Access | Times Cited: 19
Gut microbiota and metabolites signatures of clinical response in anti-PD-1/PD-L1 based immunotherapy of biliary tract cancer
Chengpei Zhu, Yunchao Wang, Ruijuan Zhu, et al.
Biomarker Research (2024) Vol. 12, Iss. 1
Open Access | Times Cited: 9
From the Colon to the Liver: How Gut Microbiota May Influence Colorectal Cancer Metastatic Potential
Irene Mignini, Giulia Piccirilli, Linda Galasso, et al.
Journal of Clinical Medicine (2024) Vol. 13, Iss. 2, pp. 420-420
Open Access | Times Cited: 8
Rapid Biodistribution of Fluorescent Outer-Membrane Vesicles from the Intestine to Distant Organs via the Blood in Mice
Béatrice Schaack, Corinne Mercier, Maya Katby, et al.
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 3, pp. 1821-1821
Open Access | Times Cited: 7
Microbiome bacterial influencers of host immunity and response to immunotherapy
Yeganeh Yousefi, Kelly J. Baines, Saman Maleki Vareki
Cell Reports Medicine (2024) Vol. 5, Iss. 4, pp. 101487-101487
Open Access | Times Cited: 7
Role of the gut microbiota in tumorigenesis and treatment
Qingya Liu, Yun Yang, Meng Pan, et al.
Theranostics (2024) Vol. 14, Iss. 6, pp. 2304-2328
Open Access | Times Cited: 7
Biofilms: A cause for the development of cancer: A review
Ankit Gupta, Debasmita Bhattacharya, Sumitha Elayaperumal, et al.
The Microbe (2025), pp. 100236-100236
Open Access
FadA antigen of Fusobacterium nucleatum: implications for ceRNA network in colorectal cancer and adenomatous polyps progression
Sama Rezasoltani, Elahe Shams, Moein Piroozkhah, et al.
Discover Oncology (2025) Vol. 16, Iss. 1
Open Access
Microbial molecules, metabolites, and malignancy
Ryan M. Thomas
Neoplasia (2025) Vol. 60, pp. 101128-101128
Closed Access
Intestinal Microbiome Modulation of Therapeutic Efficacy of Cancer Immunotherapy
Maruhen Amir Datsch Silveira, Richard R. Rodrigues, Giorgio Trinchieri
Gastroenterology Clinics of North America (2025)
Closed Access
The Role of the Microbiome in Cancer Therapies
Julia Chalif, Naomi E. S. Goldstein, Yogita Mehra, et al.
Hematology/Oncology Clinics of North America (2025)
Closed Access
Multiple programmed cell death patterns predict the prognosis and drug sensitivity in gastric cancer
Qiying Song, Shihe Liu, Di Wu, et al.
Frontiers in Immunology (2025) Vol. 16
Open Access
Gut microbiota and immunosenescence in cancer
Yaozheng Xu, Chuan He, Ying Xi, et al.
Seminars in Cancer Biology (2024) Vol. 104-105, pp. 32-45
Closed Access | Times Cited: 5
Long-distance microbial mechanisms impacting cancer immunosurveillance
Laurence Zitvogel, Marine Fidelle, Guido Kroemer
Immunity (2024) Vol. 57, Iss. 9, pp. 2013-2029
Closed Access | Times Cited: 5
Characterizations of multi-kingdom gut microbiota in immune checkpoint inhibitor-treated hepatocellular carcinoma
Chengpei Zhu, Chenchen Zhang, Shanshan Wang, et al.
Journal for ImmunoTherapy of Cancer (2024) Vol. 12, Iss. 6, pp. e008686-e008686
Open Access | Times Cited: 4
Fusobacterium nucleatum promotes inflammatory and anti-apoptotic responses in colorectal cancer cells via ADP-heptose release and ALPK1/TIFA axis activation
Camille Martin‐Gallausiaux, Laurène Salesse, Diego García‐Weber, et al.
Gut Microbes (2023) Vol. 16, Iss. 1
Open Access | Times Cited: 13
Predictive Biomarkers for Immunotherapy in Gastric Cancer: Current Status and Emerging Prospects
Wanting Hou, Yaqin Zhao, Hong Zhu
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 20, pp. 15321-15321
Open Access | Times Cited: 12
A microbial iron fist to fight tumors
Samuel Philip Nobs, Eran Elinav
Nature Immunology (2024) Vol. 25, Iss. 5, pp. 720-721
Closed Access | Times Cited: 3
Pan-cancer atlas of tumor-resident microbiome, immunity and prognosis
Dashuang Sheng, Chuandi Jin, Kaile Yue, et al.
Cancer Letters (2024) Vol. 598, pp. 217077-217077
Open Access | Times Cited: 3
Page 1 - Next Page

Scroll to top